Stay updated on our latest events, exhibitions and workshops. 


Julphar receives the Jordan Food and Drug Administration (JFDA)delegation.

Dr. Essam Farouk, CEO of Julphar receives the Director General of the Food and Drug Authority (JFDA), and Chairman of the Pharmaceutical Manufacturing Committee in the Hashemite Kingdom of Jordan, Prof.…

MEBO derma and Gyne division participated in the fifth MEIDAM hybrid Congress.

The event took place from December 10 to 11 at the Intercontinental DSF in Dubai with participation of more than 1500 delegates from the region.

Dialon - What You Should Know

1.) Why was Dialon withdrawn?   MOHAP issued a circular to medical zones, hospitals and pharmacies to withdraw diabetes medicine, Dialon 500mg, due to an issue with its solubility with the reference…

Statement Regarding Julphar's License in Saudi Arabia

"We have learned that our license to export products to Saudi Arabia had been temporarily suspended. At Julphar, we take this issue very seriously and we are working hard to fix it. It is important…
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.